As of 09-Oct-2026
4QFY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 7.4B
12MFY26: Rs 36.8B (+28.7%)
Net profit
Rs (1.8B)
12MFY26: Rs 535M (+139.0%)
EPS
Rs (3.38)
12MFY26: Rs 0.52 (+122.7%)
DPS
Rs 1.00
12MFY26: Rs 1.00
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
294.11M (50.00%)
Free Float shares
294.11M (50.00%)
Market Cap
45.80B
#5 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to SEARL by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| ABOT Abbott Laboratories (Pakistan | 926.5 | Rs 90.5B | 10.5x | 4.3% |
| HALEON Haleon Pakistan | 685.4 | Rs 78.9B | 12.1x | 4.5% |
| HINOON Highnoon Laboratories | 929.1 | Rs 49.2B | 11.8x | 5.4% |
| SEARL The Searle Company (this stock) | 77.86 | Rs 45.6B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.8B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.1B | 10.1x | 6.8% |
| CPHL Citi Pharma | 64.76 | Rs 14.6B | 19.1x | 5.5% |
The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993, the Company was converted into a public limited company under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company, which holds 56.32% shareholding in the Company. The Searle Company Limited (SEARL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100, KSE-30 and KMI-30 indices. It is marked Shariah-compliant on the KMI screening.
The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993, the Company was converted into a public limited company under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company, which holds 56.32% shareholding in the Company.
The Searle Company Limited (SEARL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100, KSE-30 and KMI-30 indices. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare SEARL with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
